ResMed, Inc. (RMD)
218.89
-2.26
(-1.02%)
USD |
NYSE |
Oct 02, 16:00
219.04
+0.14
(+0.07%)
After-Hours: 20:00
ResMed Enterprise Value : 30.93B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 30.93B |
| October 01, 2026 | 31.25B |
| September 30, 2026 | 31.24B |
| September 29, 2026 | 31.49B |
| September 28, 2026 | 31.39B |
| September 25, 2026 | 31.37B |
| September 24, 2026 | 31.36B |
| September 23, 2026 | 31.42B |
| September 22, 2026 | 31.37B |
| September 21, 2026 | 31.61B |
| September 18, 2026 | 31.81B |
| September 17, 2026 | 32.30B |
| September 16, 2026 | 32.28B |
| September 15, 2026 | 32.45B |
| September 14, 2026 | 31.52B |
| September 11, 2026 | 30.84B |
| September 10, 2026 | 31.03B |
| September 09, 2026 | 31.08B |
| September 08, 2026 | 31.24B |
| September 04, 2026 | 32.29B |
| September 03, 2026 | 32.41B |
| September 02, 2026 | 32.65B |
| September 01, 2026 | 32.72B |
| August 31, 2026 | 33.99B |
| August 28, 2026 | 34.02B |
| Date | Value |
|---|---|
| August 27, 2026 | 33.36B |
| August 26, 2026 | 33.35B |
| August 25, 2026 | 33.48B |
| August 24, 2026 | 32.88B |
| August 21, 2026 | 32.75B |
| August 20, 2026 | 32.30B |
| August 19, 2026 | 32.62B |
| August 18, 2026 | 31.08B |
| August 17, 2026 | 31.14B |
| August 14, 2026 | 31.73B |
| August 13, 2026 | 32.06B |
| August 12, 2026 | 31.95B |
| August 11, 2026 | 31.78B |
| August 10, 2026 | 31.09B |
| August 07, 2026 | 29.92B |
| August 06, 2026 | 31.55B |
| August 05, 2026 | 31.67B |
| August 04, 2026 | 31.54B |
| August 03, 2026 | 30.39B |
| July 31, 2026 | 29.78B |
| July 30, 2026 | 29.44B |
| July 29, 2026 | 30.26B |
| July 28, 2026 | 29.49B |
| July 27, 2026 | 28.65B |
| July 24, 2026 | 27.52B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| IDEXX Laboratories, Inc. | 41.79B |
| Accuray, Inc. | 180.04M |
| Micron Solutions, Inc. | -- |
| Eli Lilly & Co. | 1.122T |
| Neogen Corp. | 3.272B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 383.43M |
| Revenue (Quarterly) | 1.464B |
| Total Expenses (Quarterly) | 1.080B |
| EPS Diluted (Quarterly) | 2.645 |
| Gross Profit Margin (Quarterly) | 58.12% |
| Profit Margin (Quarterly) | 26.20% |
| Earnings Yield | 4.77% |
| Operating Earnings Yield | 6.02% |
| Normalized Earnings Yield | 4.802 |